A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis

Clinical trial NCT07071519 · RECRUITING

Trial details

NCT number: NCT07071519
Sponsor: AbbVie
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Ulcerative Colitis

Start date: 2025-07-28
Primary completion: 2034-07-01
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.